Dark mark still there after the breakout cleared? Here's the 4-stage biology of PIH on melanin-rich skin — and the honest timeline for fading it.

Adult acne is not a teenage problem that followed you.  It is a different condition entirely. Treat it that way. If you are treating adult acne with teenage acne products, you are not just using the wrong formula. You are using a formula designed for a completely different biological condition. Why Adult Acne Is Different Teenage acne is primarily driven by a surge in androgen hormones during puberty, which increases sebum production across the whole face. It tends to present as widespread whiteheads, blackheads, and inflammatory lesions, and it often improves significantly once hormone levels stabilise. Adult acne in women is primarily hormonal in a different way. It is driven by cyclical androgen fluctuations tied to the menstrual cycle, perimenopause, stress cortisol, and insulin response. It tends to concentrate in the lower face and jawline, presents as deeper cystic lesions rather than surface whiteheads, and is significantly more prone to leaving PIH marks because the skin’s healing capacity is already being compromised by the other changes happening at 35+. The Collagen Complication Here is what makes adult acne uniquely difficult: it is happening at exactly the same time as collagen loss. Collagen production begins declining in the late twenties and accelerates significantly around 35. Estimates from collagen synthesis research suggest women may lose up to 30% of dermal collagen in the first five years after menopause, with a slower ongoing decline from the mid-thirties (Varani et al., American Journal of Pathology, 2006). The skin becomes thinner, less elastic, and heals more slowly from inflammatory events. This means that the same inflammatory acne lesion that would have healed in two weeks at 20 may take six weeks at 37, leave a deeper PIH mark, and cause more collagen disruption in the surrounding tissue. The acne is not necessarily worse. The conditions it is occurring in are significantly more fragile.   Why Teenage Acne Products Make It Worse Teenage acne products are formulated for skin with high sebum production, high cell turnover, and high resilience. They are often aggressive: high-percentage benzoyl peroxide, strong AHA cycling, drying clay formulas, alcohol-based toners. Adult skin at 35+ does not have the resilience to recover quickly from these treatments. Aggressive exfoliation creates micro-inflammation that slows collagen repair. Drying actives compromise a barrier that is already thinner than it was at 20. High-percentage benzoyl peroxide, while effective at killing P. acnes, can trigger significant PIH in melanin-rich skin that is now also producing less collagen to repair the damage. The cycle looks like this: aggressive treatment, skin barrier disruption, more sensitivity and reactivity, more acne triggers, more PIH, more aggressive treatment. It is a loop designed for someone else’s skin at someone else’s age.   What Adult Acne-Prone Skin Actually Needs Barrier support first. Everything else works better when the barrier is intact — including every active you apply on top of it. Gentle actives, used consistently. Willow bark clears pores and reduces sebum daily, without the barrier disruption that high-concentration BHA causes on melanin-rich skin. Anti-inflammatory ingredients to break the breakout-to-mark cycle. Bisabolol targets the NF-κB pathway that turns inflammation into pigment. Calendula supports it. Peptides alongside the acne treatment. Acetyl Hexapeptide-8 and Hexapeptide-11 signal collagen production without any irritation mechanism — appropriate for inflamed skin. Adult hormonal acne is managed, not cured. Consistent gentle support over time outperforms aggressive short-term treatment — especially on skin where every flare risks a mark that takes months to fade. Sources: Collier et al., J Am Acad Dermatol (2008) — pubmed.ncbi.nlm.nih.gov/17945383 · PMC 12584016, Prevalence and Characteristics of Adult Female Acne (2025) — pmc.ncbi.nlm.nih.gov/articles/PMC12584016 · Varani et al., American Journal of Pathology (2006) — doi.org/10.2353/ajpath.2006.060281 · Auffret et al., Acta Derm Venereol (2025) — doi.org/10.2340/actadv.v105.42925

Post Inflammatory Hyperpigmentation is not a scar. It is a signal. Stop attacking it. Start calming the inflammation that creates it. If you have brown skin and a history of acne, you already know this story. The pimple lasts two weeks. The mark lasts six months. Sometimes a year. Sometimes longer. Post-inflammatory hyperpigmentation is not a scar. It is not permanent damage. But it is one of the most misunderstood and mismanaged skin conditions in Southeast Asian skincare, and the way most brands address it — or fail to address it — is actively making it worse for women with melanin-rich skin. Here is what is actually happening and why brown skin experiences it differently.   What PIH Is — and What It Is Not Post-inflammatory hyperpigmentation happens when the skin experiences inflammation — from acne, eczema, a cut, an insect bite, or even an aggressive skincare treatment — and the healing process triggers excess melanin production. The inflamed area produces more pigment than it needs, and that excess pigment remains visible as a dark mark once the inflammation has resolved. It is important to distinguish PIH from acne scarring. A scar involves a change in skin texture — a depression or raised area caused by collagen disruption. PIH is purely about colour. The skin surface is smooth. Only the pigment distribution has changed. This distinction matters because PIH is treatable with the right approach. But it requires patience, the right actives, and critically, an understanding of how melanin-rich skin responds differently.   Why Brown Skin Is More Vulnerable Asian skin predominantly sit in Fitzpatrick skin types III to V. This means our skin naturally has more active melanocytes — the cells responsible for pigment production. While this provides some built-in UV protection, it also means our skin is biologically primed to produce more pigment when it encounters inflammation. The more melanocytes you have, the more pigment gets produced during the healing response, and the darker and longer-lasting the resulting mark. This is not a flaw in your skin. It is your skin doing its job with more resources than it needs in that moment. UV exposure significantly amplifies pigmentation. Regions near the equator—like Malaysia and Singapore—experience consistently high UV levels year-round, which means skin is exposed to more cumulative radiation even during short periods outdoors. Even brief, unprotected sun exposure can stimulate melanin production, deepening existing marks and slowing their natural fading cycle. This is why post-inflammatory hyperpigmentation (PIH) that may resolve within a few months in lower-UV regions (like the UK) can persist much longer—often close to a year—in high-UV environments across Southeast and South Asia. What Makes It Worse — and What Most Routines Get Wrong The instinctive response to dark marks is to treat them aggressively — high-strength acids, retinoids, physical exfoliation, chemical peels. And while these approaches can accelerate cell turnover, they also create a significant risk for brown skin: if the treatment itself causes inflammation, it triggers new PIH on top of the existing marks. This is one of the most common and demoralising skin cycles for brown-skinned women. You treat the mark, the treatment irritates the skin, and you are left with a new mark where the irritation occurred. The calendar resets. You start again. The Ziva approach to PIH is grounded in a different principle: calm first, correct second. Addressing the inflammation that creates PIH is more important than attacking the pigment that results from it. A calm, barrier-intact skin will fade PIH on its own timetable — and that timetable shortens significantly when you stop creating new inflammatory events. The Right Ingredients for PIH on Brown Skin 1. Alpha-BisabololHelps calm inflammation by downregulating pathways like TNF-α, IL-1β, and NF-κB. Also supports reduction of tyrosinase activity—addressing both the cause (inflammation) and the pigment response in PIH. 2. Gentle Exfoliation (BHA, PHA, Mandelic Acid)Encourages steady cell turnover and keeps pores clear without triggering irritation. This is key—over-exfoliation can worsen inflammation and lead to more pigmentation. 3. Tyrosinase Inhibitors (Licorice, Azelaic Acid, Tranexamic Acid)Work by reducing melanin production at different stages of the pathway. With consistent use, they help fade existing marks and improve overall skin tone. 4. Barrier Support (Centella, Ceramides, Panthenol)A strong barrier reduces sensitivity and prevents repeated inflammatory triggers. This helps break the cycle of new pigmentation forming. 5. Antioxidants (Green Tea, Vitamin C, Niacinamide)Protect against oxidative stress and UV-induced melanocyte activation. They also support brighter, more even-looking skin over time. 6. SPF (Daily, Non-Negotiable)UV exposure is the biggest driver of persistent pigmentation. Even short exposure can deepen marks and delay healing—daily broad-spectrum SPF is essential.   Sources: Becker et al., PubMed PMID 35753438 (alpha-bisabolol anti-inflammatory mechanisms) · Kim et al., Journal of Investigative Dermatology, PMID 18692366 (bisabolol depigmentation) · Immunity & Ageing, Springer Nature (2025) — doi.org/10.1186/s12979-025-00498-9 (EGCG, phytochemicals) · PMC 9133606 — pmc.ncbi.nlm.nih.gov/articles/PMC9133606 (photoprotection phytochemicals) · Tyrosinase Inhibitors Review, Biofor (2025) — biofor.co.il/wp-content/uploads/2025/04/Tyrosinase-inhibitors.pdf · Auffret et al., Acta Dermato-Venereologica (2025) — doi.org/10.2340/actadv.v105.42925 (PIH treatment algorithm)

What the skin microbiome is, why it matters for acne-prone pigmented skin, and what to look for in a formula The human skin hosts over one million microorganisms — bacteria, fungi, and archaea — per square centimetre on the face. Research published in the Journal of Investigative Dermatology (Grice & Segre, 2011 — PMC 3535073) established that this microbiome is not a passive presence but an active ecosystem essential to barrier integrity and immune regulation. Most of them are doing something useful. Staphylococcus epidermis produces antimicrobial peptides that keep harmful bacteria in check and maintains the slightly acidic pH your skin needs to function. Commensal microbes regulate your skin's immune response, protect the barrier, and support the conditions in which breakouts are less likely — not more. The problem is that most skincare routines are unknowingly disrupting this ecosystem every morning and evening. How your cleanser might be feeding your acne A 2025 peer-reviewed analysis of skin microbiome and bioactive compounds (PMC 12655691, International Journal of Molecular Sciences) confirms that alkaline cleansers — the majority of foaming cleansers on the market — raise the skin's pH above its natural 4.5 to 5.5 range. This disruption directly favours the proliferation of C. acnes and S. aureus: the two bacteria most associated with inflammatory acne and skin infection. In plain terms: a cleanser that is too alkaline does not just strip your skin. It creates the conditions for more breakouts. Not immediately, not dramatically — but consistently, over months and years of twice-daily use. A pH-balanced cleanser, formulated with natural glucoside surfactants rather than alkaline synthetic detergents, maintains your skin's acidic environment. Beneficial bacteria thrive. Pathogenic bacteria cannot establish dominance. The microbiome remains in balance — and with it, the chronic low-grade inflammation that drives both acne and PIH stays lower.   Why this matters specifically for brown skin For melanin-rich, acne-prone skin, the microbiome connection to PIH is direct. Disrupted microbiome means elevated inflammation. Elevated inflammation means melanocyte overactivation. Melanocyte overactivation means more PIH — deeper, darker, and more persistent. Every element of the cycle that keeps PIH entrenched has a microbial component. The bacteria living on your skin influence how your skin heals after a breakout, how long inflammation persists, and how aggressively your melanocytes respond. A formula that supports the right microbial balance does not just cleanse — it actively reduces the conditions that create PIH in the first place. A 2025 review published in Annals of Dermatology (Cho et al., 2025 — doi.org/10.5021/ad.25.009) confirmed that microbiome-supportive skincare works by reducing inflammation, enhancing antioxidant defences, and regulating skin pH simultaneously. These are the three mechanisms that matter most for acne-prone, pigmented skin in a humid, high-UV environment. They are also the three mechanisms that most cleansers — even those marketed as natural — inadvertently undermine.   What a microbiome-intelligent formula looks like It uses mild surfactants that clean without raising pH above 5.5. It avoids synthetic preservatives that kill beneficial bacteria indiscriminately alongside harmful ones. It includes botanical actives that support microbial diversity rather than disrupting it. And it is formulated for the climate in which it will be used — because humidity, UV exposure, and pollution levels all influence the microbial landscape of your skin in ways that a formula developed for London in October simply cannot account for. The takeaway The bacteria on your skin are not passengers. They are active participants in whether your skin breaks out, how quickly it heals, how deeply PIH marks form, and how much inflammation your skin carries between breakouts. A formula that respects this ecosystem is not merely gentle. It is working with a biological system of extraordinary complexity — and giving your skin the conditions it needs to regulate itself. That is what barrier-first, microbiome-intelligent formulation means. And it is why Ziva was built the way it was.   Sources: Cho et al., Annals of Dermatology (2025) — doi.org/10.5021/ad.25.009 · Skin Microbiome and Bioactive Compounds, PMC (2025) — pmc.ncbi.nlm.nih.gov/articles/PMC12655691 · Grice & Segre, Journal of Investigative Dermatology (2011) — pmc.ncbi.nlm.nih.gov/articles/PMC3535073 · Genoskin Microbiome Review (2026) — genoskin.com/skin-microbiome-in-skin-care · Frontiers in Medicine, Multi-omic Microbiome Study (2023) — doi.org/10.3389/fmed.2023.1165980